|
| 2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-[1-(phenylmethyl)-4-piperidinyl]-2H-isoindol-2-yl]- Basic information |
| 2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-[1-(phenylmethyl)-4-piperidinyl]-2H-isoindol-2-yl]- Chemical Properties |
Boiling point | 661.8±55.0 °C(Predicted) | density | 1.281±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 62.5 mg/mL (149.70 mM; ultrasonic and warming and heat to 60°C) | form | Solid | pka | 10.73±0.40(Predicted) | color | White to off-white |
| 2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-[1-(phenylmethyl)-4-piperidinyl]-2H-isoindol-2-yl]- Usage And Synthesis |
Biological Activity | NVP-DKY709 is a potent IKZF2 inhibitor for the treatment of cancers. | References | [1]. Simone BONAZZI, et al. Dosing regimen and pharmaceutical combination comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives. WO2020128972 A1. |
| 2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-[1-(phenylmethyl)-4-piperidinyl]-2H-isoindol-2-yl]- Preparation Products And Raw materials |
|